US Health Insurers Simplify Prior Authorization for Certain Medical Treatments

Several leading US health insurers, including UnitedHealthcare, Aetna, Humana, and CVS Health's Aetna, have introduced measures to simplify the prior authorization process for certain medical treatments. Industry groups, such as the American Medical Association and the Blue Cross Blue Shield Association, reported these developments on Wednesday.

The changes involve reducing the number of services requiring prior approval and automating parts of the process.

Prior authorization requires physicians to obtain insurer approval before providing specific treatments to ensure medical necessity and cost control. According to the industry groups, the insurers have eliminated prior authorization requirements for over 100 services deemed low-risk, such as certain imaging tests and routine medications.

These modifications apply to Medicare Advantage plans and commercial insurance products.

The adjustments come in response to a 2023 report by the Centers for Medicare & Medicaid Services (CMS), which highlighted delays in patient care due to lengthy prior authorization processes.

In March 2024, CMS finalized rules mandating faster response times from insurers, with decisions required within 72 hours for expedited requests. Industry groups noted that the recent insurer actions align with these federal guidelines to improve efficiency. Physicians and patient advocacy organizations have long criticized prior authorization for causing treatment delays.

A 2022 AMA survey found that 94% of doctors reported care delays due to the process, affecting millions of patients annually. The stakes involve balancing cost containment with timely access to care, particularly for chronic conditions like diabetes and cancer.

Steps Doctors, particularly in primary care and specialties like cardiology and oncology, stand to benefit from reduced paperwork.